Honoring the Life of an Advocate

In the fall issue, Cancer Today had the honor of highlighting two women whose cancer diagnoses led them to form a powerful partnership. AnneMarie Ciccarella and Lori Marx-Rubiner met each other after attending a weekly Twitter chat under the social media hashtag #BCSM (for Breast Cancer Social Media). They formed an unbreakable bond that challenged them both—and ultimately affected many researchers.

Read More

Learning From the Immune System of Long-term Pancreatic Cancer Survivors

November is pancreatic cancer awareness month.

A look at the statistics from the SEER database is a stark reminder that pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent. Unfortunately, the last 30 years has not seen any significant improvement in survival for patients with this disease. Pancreatic cancer is projected to become the second leading cause of deaths due to cancer in the United States by 2030.

Read More

Advances in Tobacco Control

Cigarette smoking is the leading cause of death from lung cancer in the United States. That’s why November, Lung Cancer Awareness Month, is a good time to highlight new advances in tobacco control, such as the legislation that came into effect Nov. 1, 2017, in New Jersey that raises the minimum age of legal access to tobacco products to 21.

Read More

Treating DNA Repair-deficient Breast Cancers

Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers, because they often harbor BRCA mutations and DNA repair deficiencies. Emerging studies show that the benefit of PARP inhibitors could extend beyond breast cancers with germline BRCA mutations.

Read More

NextGen Grant Recipient Harnesses the Power of Genomics to Understand Pediatric Brain Cancer

Paul Northcott, PhD, inaugural recipient of the AACR NextGen Grant for Transformative Cancer Research, has dedicated his research career to understanding a type of brain cancer called medulloblastoma, with the ultimate goal of improving treatment and prognosis for patients.

Read More

AACR, NCI, and EORTC to Host Meeting on Molecular Targets

Beginning this Friday, Philadelphia will host the 2017 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. The conference, held each year by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer, brings together some of the world’s leading cancer scientists to discuss the discovery, biology, and clinical applications of novel cancer therapeutics.

Read More